Solid-phase peptide synthesis (SPPS) is the foundational method behind virtually all research-grade peptides available today. Understanding how peptides are made — and where the process can introduce variability — helps researchers make better sourcing decisions, interpret COA data more accurately, and troubleshoot unexpected assay results.
The Basics of Solid-Phase Synthesis
SPPS builds a peptide chain one amino acid at a time, anchored to an insoluble solid support (resin). The process is sequential and iterative: each cycle adds one amino acid residue, moving from the C-terminus to the N-terminus.
The core cycle has three steps:
- Deprotection: The protecting group on the N-terminal amine of the growing chain is removed (typically with piperidine for Fmoc-SPPS)
- Coupling: The next protected amino acid is activated and coupled to the free amine using a coupling reagent
- Washing: Excess reagents and byproducts are washed away before the next cycle begins
After all residues are assembled, the peptide is cleaved from the resin and side-chain protecting groups are removed simultaneously using a cleavage cocktail (typically TFA-based). The crude peptide is then purified by HPLC and lyophilized.
Fmoc vs. Boc Chemistry
Two main protection strategies exist for SPPS. Most research peptides today are produced via Fmoc (9-fluorenylmethoxycarbonyl) chemistry, which uses mild base for deprotection and milder acid (TFA) for cleavage. This makes it compatible with a wider range of amino acid side chains and reduces epimerization risk.
Boc (tert-butyloxycarbonyl) chemistry uses HF for cleavage — effective but requires specialized equipment and poses safety considerations. Boc chemistry has some advantages for difficult sequences and certain post-translational modification analogues.
When a COA or supplier documentation specifies the synthesis method, Fmoc-SPPS is the current standard for research-grade peptide production at commercial scale.
Where Impurities Come From
No coupling reaction achieves 100% efficiency. Each cycle that fails to couple leaves a truncated sequence — a peptide missing one or more amino acids — attached to the resin. These truncated sequences are released during cleavage alongside the full-length product.
Common impurity types in HPLC chromatograms
The key insight is that impurities in a peptide sample are not random contamination — they are structurally related to the target compound. A deletion sequence missing alanine at position 3 of BPC-157 will have a molecular weight 71 Da lighter than the full sequence and may partially overlap with the main HPLC peak depending on chromatographic resolution.
This is why HPLC purity matters, why mass confirmation matters, and why the difference between 95% and 99% purity carries biological weight beyond a simple percentage.
What Purification Removes (and What It Doesn’t)
Preparative HPLC purification — the step between crude synthesis and final product — separates compounds based on differential interaction with a reverse-phase stationary phase. The target compound elutes in a defined retention window; fractions are collected and pooled.
HPLC purification effectively removes deletion sequences and oxidized forms that have clearly different retention times. It is less effective at resolving isomers (same MW, similar retention time) or impurities that co-elute with the main peak due to similar hydrophobicity.
For research applications requiring high confidence in sequence identity, mass spectrometric verification of the purified product is the only method that can confirm the correct sequence is present, not merely a molecule of the correct mass at the correct elution time.
Applying This to Sourcing Decisions
Understanding the synthesis process puts the COA in proper context. When you see a ≥99% HPLC purity figure alongside LC-MS confirmation, you can interpret this as: the material has been purified to a level where structurally distinct impurities are below 1% by UV absorbance, and the dominant peak has been confirmed as the correct molecular entity by mass.
When you see only a purity claim with no mass data, or HPLC data from an in-house instrument with no named independent lab, the claim is verifiable only by you — which requires access to your own analytical chemistry instrumentation, or accepting the number on trust.
Third-party verification by a named laboratory with public result archives eliminates this trust dependency. It is the current gold standard for research-grade peptide documentation precisely because it converts a supplier claim into an independently reproducible measurement.
This article is for informational purposes for qualified researchers. All peptides sold by Bastion Peptides LLC are intended for in vitro research and laboratory use only. Not for human or animal consumption. Not approved by the FDA for therapeutic use.
